Back to 
Empower Advisory Group, LLC
Empower Advisory Group, LLC
CDLX
Showing 0 of 2 quarters
Position history for Empower Advisory Group, LLC's holdings in CARDLYTICS INC
No. Empower Advisory Group exited its CDLX (Cardlytics) position in Q2 2023. Its Q1 2023 13F listed 39,395 shares worth $135,913. Empower Advisory Group already held CDLX in its Q1 2023 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.